Efficacy and Toxicity of Vincristine and CYP3A5 Genetic Polymorphism in Rhabdomyosarcoma Pediatric Egyptian Patients
CONCLUSION: CYP3A5*1/*1 have less severe vincristine-induced neuropathy than CYP3A5 *1/*3, CYP3A5 *1/*6 and CYP3A5 *3/*3, CYP3A5 *3/*6. There is a significant influence of CYP3A5 mutation on neuropathy grade and assist of ADL as a part of neurotoxicity.PMID:38680001 | DOI:10.31557/APJCP.2024.25.4.1391
Source: Asian Pacific Journal of Cancer Prevention - Category: Cancer & Oncology Authors: Norhan Shalaby Hala F Zaki Osama A Badary Sherif Kamal Mohamed Nagy Dalia Makhlouf Amr Elnashar Enas Elnadi Sameh A Abdelshafi Sherif Abouelnaga Mona M Saber Source Type: research
More News: Bladder Cancer | Brain | Cancer | Cancer & Oncology | Cancer of the Uterus | Egypt Health | Genetics | Neurology | Pediatrics | Rhabdomyosarcoma | Study | Toxicology